Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |